DRSK ETF Analysis: Aptus Defined Risk | BATS

Intermediate Core-Plus Bond | BATS, USA | Market Cap: 1.458m USD | 12M Return: -0.8% | US26922A3885 | Charts, Fundamentals & Technical Analysis

Corporate Bonds, U.S. Equities, Downside Hedging, Hybrid Allocation
Total Rating 40
Safety 80
Buy Signal -0.74
Intermediate Core-Plus Bond
Category Rotation: +6.3
TER: 0.78%
AUM: 1.46B
Avg Turnover: 3.99M
Risk 3d forecast
Volatility7.63%
VaR 5th Pctl1.28%
VaR vs Median-7.15%
Reward TTM
Sharpe Ratio-0.59
Rel. Str. IBD30.9
Rel. Str. Peer Group92.1
Character TTM
Beta0.426
Beta Downside0.367
Hurst Exponent0.462
Drawdowns 3y
Max DD7.20%
CAGR/Max DD1.31
CAGR/Mean DD5.91

Warnings

Fakeout
Below Sma 200d

Tailwinds

No distinct edge detected

Seasonality 8.1 years of data

Jan -0.2% 9
Feb +0.0% 6
Mar -1.2% 23
Apr -0.2% 22
May +0.9% 41
Jun +0.0% 9
Jul -0.4% 10
Aug -0.0% 2
Sep -3.1% 76
Oct -1.2% 7
Nov +0.1% 6
Dec -0.2% 6

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: DRSK Aptus Defined Risk

The Aptus Defined Risk ETF (DRSK) is an actively managed exchange-traded fund that employs a hybrid strategy combining fixed income and equity exposure. The fund allocates approximately 75% to 95% of its assets to investment-grade corporate bonds, with the remaining portion invested in U.S. stocks under a defined risk framework designed to limit downside exposure. The fund is classified within the Intermediate Core-Plus Bond category, reflecting its bond-heavy allocation.

DRSK launched in August 2018 and is listed on the BATS exchange. Its hybrid structure allows investors to gain traditional fixed income exposure while participating in equity markets with built-in risk management, typically through options-based hedging strategies used to define and cap potential losses on the equity portion of the portfolio.

Headlines to Watch Out For
  • Fed rate cuts pressure investment-grade corporate bond yields
  • Widening credit spreads weigh on intermediate core-plus bond returns
  • Rising hedging costs erode equity sleeve performance
What is the price of DRSK shares?

As of September 27, 2026, the stock is trading at USD 27.62 with a total of 95,908 shares traded. Over the past week, the price has changed by -0.70%, over one month by -3.07%, over three months by -4.00% and over the past year by -0.82%.

Current recommended Stop Loss: 27.20 (which is 1.5% or 2.2 ATR below the current price).

Is DRSK a buy, sell or hold?

Aptus Defined Risk has no consensus analysts rating.